|
|
TORONTO, June 30, 2018 /CNW/ - The Canadian Life and Health Insurance Association (CLHIA) welcomes the changes to OHIP+ announced today by the Ontario Minister of Health and Long-Term Care Christine Elliott. "These important changes will ensure that all young Ontarians age 24 and under can access the prescription medicines they need in a way that is affordable for Ontario taxpayers," stated Stephen Frank, CLHIA's President and CEO.
"The life and health insurance industry is committed to working with the Government of Ontario to ensure a smooth transition and is pleased to extend the transition period agreed to with the previous government beyond July 1st. We will work closely with the new government to ensure that all those who are eligible for coverage under an employer sponsored health benefit plan are transitioned back from the OHIP+ Children and Youth Pharmacare program with minimal disruption," noted Mr. Frank. More than 9.8 million plan members and their dependents in Ontario rely on their health benefit plans to access a wide variety of medicines and other health services.
"The changes will also ensure the health benefit plans that Ontario families value remain strong and sustainable," he added. "We congratulate the new Ontario government on moving decisively on this matter that will benefit all Ontarians," concluded Mr. Frank.
About the CLHIA
The CLHIA represents life and health insurance companies accounting for 99% of the business in Canada. The industry provides a strong social safety net for Ontarians. It pays almost $40 billion in benefits each year to Ontarians through life and health insurance products including annuities, RRSPs, disability insurance and supplementary health plans. Life and health insurers pay over $1 billion in taxes in Ontario, and collect almost $1.5 billion in retail sales tax on workplace life and health insurance products, for a total of $2.5 billion in taxes on the industry and its products.
SOURCE Canadian Life and Health Insurance Association Inc.
For further information:
Susan Murray, Vice President, Government Relations and Policy, (613) 691-6002/smurray@clhia.ca; Wendy Hope, Vice President, External Relations, (613) 691-6001/whope@clhia.ca
|
||
|
TORONTO, June 28, 2018 /CNW/ - The Metro Toronto Convention Centre (MTCC) is pleased to announce that it will host seven citywide medical conventions in 2018. June 2018 stands as the busiest month in MTCC history for international medical conventions, three have taken place in this month alone on topics that include atherosclerosis and blood transfusion.

Together, this year's major medical conventions will bring thousands of leading medical professionals to Toronto, generate an estimated $55 million in economic impact for the community, and help solidify the city's position as a world-class hub for medical expertise. The transfer of knowledge from medical experts attending major conventions in many instances lead to lifesaving changes in medical care around the world and leave a legacy of ideas, research and innovation for Toronto.
Toronto is home to a thriving life sciences sector that employs more than 36,000 people in fields that include medical research, biotechnology and medical technology. The city is Canada's largest centre of life sciences activity, with more than 1,400 clinical trials and $1 billion in research and development.
Citywide medical conventions rotate the destination of their meeting around the world and for some the highly-competitive bidding process begins 5+ years in advance. In many cases, a winning bid requires support from a local expert or organization and is contingent on the combined efforts of the MTCC, Tourism Toronto and the Leaders Circle. In fact, four citywide medical meetings taking place at the MTCC this year were brought to Toronto as a direct result of this partnership and with the support of local experts, also recognized as Leaders Circle Ambassadors.
"Toronto is home to a strong network of medical experts who are dedicated to innovation and research," said Barry Smith, President and CEO at the Metro Toronto Convention Centre. "We are certainly proud to help bring major medical meetings to the city that shine a spotlight on Toronto's successful life sciences sector."
"Toronto has the largest life sciences sector across Canada, employing 36,000 people from biotechnology to pharmaceuticals," said Tara Gordon, VP, Sales & Service, Business Events Toronto. "Our life sciences sector is thriving, and that's why so many in the industry around the world are choosing Canada's Downtown to host their conferences, meetings and events – further cementing Toronto's place as a global leader in health care and innovation."
About the Metro Toronto Convention Centre
The Metro Toronto Convention Centre is Canada's number one convention and trade show facility. Over the past 33 years, the Centre has hosted over 20,000 events and has added $6.3 billion in direct spending economic impact to the community. For further information, please visit www.mtccc.com.
SOURCE Metro Toronto Convention Centre
For further information:
Melanie Wade, Social Media and Communications Specialist, Metro Toronto Convention Centre, T: (416) 585-8504, E: mwade@mtccc.com
The Devastating Connection Between Lead Pollution and Fertility
Sexual health expert Dr. Laura Berman discusses new findings that show the insidious impact of lead on reproductive health
Lead pollution in Flint, Michigan has caused fetal deaths to increase by as much as 50%. Now, new research from Carnegie Mellon University has found that airborne lead exposure has lowered the general fertility rate in recent years.
“For years, the link between lead exposure and fertility has been researched,” says Dr. Laura Berman, sexual health expert and television host. “We now know that exposure to lead, even airborne exposure via topsoil, can harm our reproductive abilities.”
Dr. Berman says that concerned couples can take several steps to safeguard their fertility, including having their home tested for lead and using water filters to help remove lead from drinking water.
“But, beware, not all water filters are created equal,” says the sexual health expert and New York Times bestselling author. “For example, refrigerator water filter units generally do not have the capability to remove lead from water.”
In addition to limiting your exposure to harmful lead, Dr. Laura Berman advises hopeful couples to also consider other lifestyle choices which could be impacting your ability to become pregnant, including:
ToConcieve was created by ob-gyns in conjunction with Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2). The fertility enhancing gel is unlike any other fertility product on the market in that it actually encourages the woman’s body to create more of her own lubricant, which in turn may increase the activation of sperm and the woman’s chances of pregnancy. Unlike every other lubricant on the market, ToConceive doesn’t just add chemical lubricants to a woman’s body, it actually encourages her to make more of her own natural lubricant which not only adds to her pleasure, but also may improve her chances of natural conception.
“This ground-breaking product is going to change the way that couples approach their fertility journey,” says Dr. Berman. “Now they have something over the counter that they can use before they have to spend the time and money on interventions at the doctor’s office.”
For more on this topic or to speak to Dr. Berman about ToConcieve and how it can help improve a woman’s chance of becoming pregnant, please contact me.
About Dr. Laura Berman:
Laura Berman, PhD, is a world-renowned sex and relationship educator and therapist; popular TV, radio and Internet host; New York Times best-selling author; and assistant clinical professor of ob-gyn and psychiatry at the Feinberg School of Medicine at Northwestern University in Chicago. Considered a thought leader in her field, Dr. Berman has helped countless couples build stronger relationships, improve their sex lives, and achieve a heightened level of intimacy through her TV and radio shows, books, columns and website, along with her private practice based in Chicago. Dr. Berman is a New York Times best-selling author of many books on sexual health and pleasure, a weekly columnist for the Chicago Sun Times, and host of the radio program “Uncovered with Dr. Laura Berman.” She has appeared on Fox News, CNN and the TODAY Show, as well as in The New York Times, USA Today, and every major woman’s magazine. Dr. Berman serves on the advisory board for The Dr. Oz Show and is a regular guest on The Steve Harvey Show.
MONTREAL, June 28, 2018 /CNW/ - Chronic illnesses affect millions of Canadians and require them to spend considerable time in hospitals and healthcare centres. The National Research Council of Canada (NRC) and Greybox Solutions Inc. developed an innovative "virtual assistant" — an Artificial Intelligence (AI) health monitoring solution for Greybox's existing TakeCare secure health monitoring platform — to help patients, their healthcare providers, and caregivers remotely manage chronic conditions such as diabetes, hypertension, and heart failure.
With the help of this virtual assistant, patients can educate themselves and manage their own progress from home, while supporting healthcare professionals in triage procedures. The virtual assistant can guide patients through tasks to collect medical data like health parameters and lifestyle habits, and provide adaptive information based on the patient's emotional and physical state.
In addition to helping patients maintain a healthier lifestyle, the virtual assistant provides data and personalized recommendations to healthcare professionals, which translates to more quality time with doctors during visits instead of time spent filling in forms.
For patients with diseases that require specific and rigorous monitoring, such as diabetes and heart conditions, the virtual assistant is programmed to ask personalized questions targeted to the patient's condition. Data from these interactions is gathered, analysed, organized, and displayed to healthcare professionals in a user-friendly manner, providing them with pertinent patient information on a regular basis.
Greybox, and its clinical partners located across Canada, plan to launch the diabetes, hypertension, and heart failure virtual assistant programs in several hospitals for a commercial deployment late in 2018.
Quotes
"We are proud to participate in this collaboration to provide an accessible digital health monitoring tool for improving the health of Canadians, especially those in remote regions or with reduced mobility. The National Research Council's dedicated and recognized medical devices experts are creating virtual assistant applications that empower patients while creating regular and essential data transfer to their health professionals for more efficient health monitoring."
Dr. Roman Szumski, Vice-President of Life Sciences at the National Research Council of Canada
"We are pleased to be able to count on the National Research Council's expertise to expand our offer to other healthcare areas. Their expertise in the artificial intelligence field and biomedical software engineering, as well as their access to clinicians to guide the development of a product, is a distinct advantage when it comes to developing a product that meets a specific need."
Pierre Bérubé, Founder and CEO, Greybox Solutions Inc.
Quick facts
Follow the NRC on Twitter: @NRC_CNRC
Follow Greybox on Twitter: @GreyboxSolution
SOURCE National Research Council Canada
Transatlantic collaboration between the London-based medical Artificial Intelligence (AI) company and the Royal College of Physicians, Stanford Primary Care and Yale New Haven Health yields significant breakthrough
LONDON, June 27, 2018 /CNW/ - Babylon Health tonight announced a world-first during a presentation streamed live from London's Royal College of Physicians: The company's AI, in a series of robust tests (including the relevant sections of the MRCGP exam), has demonstrated its ability to provide health advice which is on-par with practicing clinicians[1].
The MRCGP exam is the final test for trainee General Practitioners (GPs), set by the Royal College of General Practitioners (RCGP). Trainee GPs who pass this assessment have demonstrated their competence and clinical skills to a level which is sufficiently high enough for them to undertake independent practice.
A key part of this exam tests a doctor's ability to diagnose.
1. Babylon's technology provides health information, rather than a medical diagnosis, for regulatory reasons. The tests carried out relate to the diagnostic exams taken by doctors as a benchmark for accuracy, however, Babylon's AI service remains an information service, rather than a medical diagnosis.
Babylon took a representative sample-set of questions testing diagnostic skills from publicly available RCGP sources[2], as well as independently published examination preparation materials, and mapped these to the current RCGP curriculum in order to ensure the questions resembled actual MRCGP questions as closely as possible.
The average pass mark over the past five years for real-life doctors was 72%[3]. In sitting the exam for the first time, Babylon's AI scored 81%. As the AI is continues to learn and accumulate knowledge, Babylon expects that subsequent testing will produce significant improvements in terms of results.
Important though exams are, doctors are presented with a much wider range of illnesses and conditions in their daily practice. Therefore, to further test the AI's capabilities, Babylon's team of scientists, clinicians and engineers next collaborated with the Royal College of Physicians, Dr Megan Mahoney (Chief of General Primary Care, Division of Primary Care and Population Health, Stanford University), and Dr Arnold DoRosario (Chief Population Health Officer, Yale New Haven Health) to test Babylon's AI alongside seven highly-experienced primary care doctors using 100 independently-devised symptom sets (or 'vignettes').
Babylon's AI scored 80% for accuracy, while the seven doctors achieved an accuracy range of 64-94%.
The accuracy of the AI was 98% when assessed against conditions seen most frequently in primary care medicine. In comparison, when Babylon's research team assessed experienced clinicians using the same measure, their accuracy ranged from 52-99%.
2. As the RCGP does not publish past papers, Babylon used example questions - some published directly by the College, some which were sourced from publicly available resources (which all are referenced) - during its AI exam preparation and testing.
3. Average CSA pass mark by trainee GPs was calculated using publicly available RCGP test result data from the period 2012 - 2017.
Crucially, the safety of the AI was 97%. This compares favourably to the doctors, whose average was 93.1%.
Dr Ali Parsa, Babylon's Founder and CEO said of tonight's news: "The World Health Organisation estimates that there is a shortage of over 5 million doctors globally, leaving more than half the world's population without access to even the most basic healthcare services. Even in the richest nations, primary care is becoming increasingly unaffordable and inconvenient, often with waiting times that make it not readily accessible. Babylon's latest artificial intelligence capabilities show that it is possible for anyone, irrespective of their geography, wealth or circumstances, to have free access to health advice that is on-par with top-rated practicing clinicians.
"Tonight's results clearly illustrate how AI-augmented health services can reduce the burden on healthcare systems around the world. Our mission is to put accessible and affordable health services into the hands of every person on Earth. These landmark results take humanity a significant step closer to achieving a world where no-one is denied safe and accurate health advice."
Babylon's research paper, entitled Evaluation of AI Powered Symptom Checker, can be downloaded from the company's website and will be available over coming days via ArXiv.com.
About Babylon
Babylon's mission is to put an accessible and affordable health service in the hands of every person on earth. Babylon uses a combination of cutting-edge technology and the best available medical expertise to deliver 24-hours-a-day, 7-days-a-week access to digital health tools (including health assessment, triage and health tools), to people across Europe, North America, Asia, the Middle East and Africa, as well as video doctor consultations.
For more information, please visit: https://www.babylonhealth.com/
To access photographs and b-roll assets from tonight's event, visit:https://www.babylonhealth.com/press/assets
To access the research paper as well as additional copies of this press release, visit:https://www.babylonhealth.com/press/press-room
SOURCE Babylon Health

FDA APPROVED NON-SURGICAL BALLOON WEIGHT LOSS METHODHELPS PEOPLE SHED UP TO 50 POUNDS
Americans spend almost 60 billion dollars annually in pursuit of weight loss with gastric bypass surgery being the most common type of weight-loss surgery; an option that isn’t for everyone. Like any major procedure, gastric bypass has significant health risks and side effects. In addition, to be a candidate for the procedure, one must have a BMI (body mass index) of 40 or higher. The fact is, a huge percentage of the population are only between 15 to 50 pounds overweight without any other options besides diet and exercise. Dr. Stanley Poulos, a San Francisco board certified plastic surgeon is an early adaptor of the non -surgical balloon weight loss method approved by the FDA in 2016. Following the two-part program, patients lost an average 3.1x the weight compared with diet & exercise alone.
Dr. Poulos stresses that, “there is a direct correlation between those patients who stay connected to their program and their weight loss success.” Dr. Poulos is highly experienced in body contour plastic surgery which is sometimes required after major weight loss. Sometimes, due to skin laxity after weight loss, procedures such as thigh lift, breast lift, liposuction or “tummy tuck” are desired by patients.
Who is an ideal candidate for the balloon weight loss method?
It is appropriate for patients with a BMI of 30 to 40 that have not had previous weight loss surgery. Patients diagnosed with bulimia, binge eating, compulsive overeating, high liquid calorie intake habits or similar eating related psychological disorders are not good candidates.
How does the balloon method work?
This non-surgical outpatient procedure begins with a diagnostic endoscopy to ensure that there are no contraindications and that it is safe to perform. Once the patient is mildly sedated and comfortable, the procedure can begin. The deflated gastric balloon is inserted through the esophagus and into the stomach. A syringe is then used to fill the balloon with a sterile saline solution. Once the weight loss balloon has been filled with saline, it expands to approximately the size of a grapefruit. The entire procedure takes about 20 minutes. Patients can usually return home after the placement or removal procedures within 30 minutes. Over the last 20 years this procedure has helped over 277,000 people. The gastric balloon encourages portion control while patients make healthy changes to diet and lifestyle.
How long does the balloon stay in place?
The balloon remains in the stomach for the first six months after the procedure. With the stomach balloon and Dr. Poulos’ support team, patients usually see the most drastic results in the first six months. It is very important to use this time to develop healthy habits that will continue for not only the 12-month weight loss program, but for the rest of one’s life.
What to expect after the balloon placement.
Over the first 14 days after placement, patients may experience nausea or vomiting. Dr. Poulos recommends a liquid diet for his patients during the first week to help manage these symptoms. Also prescribed are effective anti-nausea drugs to help the patient through the initial stage.
How is the balloon removed?
Once the stomach balloon has been in place for six months the balloon is removed. The simple and non-surgical procedure is very similar to the placement process. Once the gastric balloon has been removed, it is very important to continue working closely with Dr. Poulos’ team and coaches to follow the personal diet and exercise plan provided. This will help to keep you in a positive and healthy mindset while achieving your weight loss goals.
Additional benefits of the balloon weight loss method.
ü It’s been shown that the average person loses 3x more weight with this procedure than with diet and exercise alone. Here are some of the reasons why:
ü Diets can leave you feeling hungry or dissatisfied. This procedure helps by taking up room in the stomach and encouraging portion control.
ü When you’re overweight, exercise can be challenging and uncomfortable. With The Balloon Weight Loss Method aiding your weight loss, physical activity can be more comfortable.
ü There are no incisions, stitches, or scars.
ü Unlike gastric bypass surgery, this procedure is not solely for the morbidly obese.
ü The procedure takes 20 minutes and most patients return home the same day.
ü The balloon is only placed temporarily.
ü The procedure is intended to work with a fitness and nutrition regimen for optimal results.
Cost: The general cost for the procedure is $8,000 to $10,000 nationwide and can be used with patients 22 and older who fit all of the medical criteria.
About Dr. Stanley Poulos
Dr. Poulos specializes in cosmetic breast surgery and body contouring procedures. He helped pioneer the quick lift facial rejuvenation surgery in California and is recognized as one of the leading plastic surgeons in Marin County and the entire San Francisco Bay area. Dr. Poulos and Plastic Surgery Specialists have extensive experience in body contour procedures. A graduate of the University of Texas Medical School, Dr. Poulos completed his internship and residency at UC San Francisco. He completed a plastic surgery fellowship at St. Francis Hospital in San Francisco and is certified by the American Board of Plastic Surgery. www.psspecialists.com
War, lack of democracy and urbanisation contribute to double burden of malnutrition in adolescents in developing countries
A new study from the University of Warwick blames macro-level factors for the double burden of malnutrition among adolescents in developing countries.
The double burden of malnutrition refers to the coexistence of undernutrition along with overweight and obesity, or diet-related noncommunicable diseases such as type 2 diabetes.
The study The double burden of malnutrition among adolescents: analysis of data from the Global School‐Based Student Health and Health Behaviour in School‐Aged Children Surveys in 57 low‐income and middle‐income countriessuggests that factors including war, lack of democracy, food insecurity, urbanisation and economic growth are to blame.
The study was published in the American Journal of Clinical Nutrition (AJCN) and was led by Dr Rishi Caleyachetty, Assistant Professor, Warwick Medical School.
His team found that the burden of double malnutrition is shockingly common and the researchers are now calling on governments and NGOs to identify context-specific issues and design and implement policies and interventions to reduce adolescent malnutrition accordingly.
The study set out to quantify the magnitude of the double burden of malnutrition among adolescents and explain the varying burden of adolescent malnutrition across low- and middle-income countries (LMICs).
Adolescence is a period for growth and development, with higher nutritional demands placing adolescents at greater risk of malnutrition.
They used data from the Centers for Disease Control and Prevention/World Health Organisation (WHO) Global School-Based Student Health Survey and WHO Health Behaviour in School-Aged Children surveys done in 57 LMICs between 2003-2013, comprising 129,276 adolescents aged 12-15 years. They examined the burden of stunting, thinness, overweight or obesity, and concurrent stunting and overweight or obesity. They then linked nutritional data to international databases including the World Bank, Center for Systemic Peace, Uppsala Conflict Data Program, and the Food and Agriculture Organization (FAO).
They found that across the 57 LMICs, 10.2% of the adolescents were stunted and 5.5% were thin. The prevalence of overweight or obesity was much higher at more than a fifth of the adolescents (21.4%). The prevalence of concurrent stunting and overweight or obesity was 2.0%. Between 38.4%-58.7% of the variance in adolescent malnutrition was explained by macro-level contextual factors.
Dr Caleyachetty said: “The majority of adolescents live in LMICs but the global health community has largely neglected the health needs of this population. At the population level, macro-level contextual factors such as war, lack of democracy, food insecurity, urbanisation and economic growth partly explain the variation in the double burden of malnutrition among adolescents across LMICs.
“The global health community will have to adapt their traditional response to the double burden of malnutrition in order to provide optimal interventions for adolescents.”
ENDS
For more information contact Nicola Jones, Media Relations Manager, University of Warwick N.Jones.1@warwick.ac.uk or 07920531221
Notes to Editors
List of countries
|
African Region |
|
Algeria |
|
Benin |
|
Ghana |
|
Mauritania |
|
Republic of Mauritius |
|
Sudan |
|
Swaziland |
|
Uganda |
|
Americas Region |
|
Argentina |
|
Belize |
|
Bolivia |
|
British Virgin Islands |
|
Chile |
|
Costa Rica |
|
Dominica |
|
Guatemala |
|
Guyana |
|
Honduras |
|
Jamaica |
|
Peru |
|
St. Kitts & Nevis |
|
Suriname |
|
Uruguay |
|
Eastern Mediterranean Region |
|
Djibouti |
|
Egypt |
|
Iraq |
|
Jordan |
|
Lebanon |
|
Libya |
|
Morocco |
|
Pakistan |
|
Palestine |
|
Syria |
|
Yemen |
|
European Region |
|
Bulgaria |
|
Macedonia |
|
Romania |
|
Russia |
|
Turkey |
|
Ukraine |
|
South-East Asia Region |
|
India |
|
Indonesia |
|
Malaysia |
|
Myanmar |
|
Sri Lanka |
|
Thailand |
|
Western Pacific Region |
|
China |
|
Cook Islands |
|
Fiji |
|
Kiribati |
|
Nauru |
|
Niue |
|
Philippines |
|
Samoa |
|
Solomon Islands |
|
Tonga |
|
Vanuatu |
Thinness was defined as BMI-for-age <2 standard deviations (SDs) below the WHO Growth Reference median.
The double burden of malnutrition among adolescents: analysis of data from the Global School-Based Student Health and Health Behaviour in School-Aged Children Surveys in 57 low-income and middle-income countries published in the American Journal of Clinical Nutrition (AJCN)
Authors:
Rishi Caleyachetty: Warwick Medical School, University of Warwick, Gibbet Hill Road, Coventry, UK; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
GN Thomas; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
Andre P Kengne: South African Medical Research Council and University of Cape Town, Cape Town, South Africa; The George Institute for Global Health, Sydney, Australia
Justin B Echouffo-Tcheugui: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Samantha Schilsky: George Washington University School of Medicine and Health Sciences, Washington DC, USA
Juneida Khodabocus: University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, UK
Ricardo Uauy: University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, UK: Institute of Nutrition and Food Technology, University of Chile, Santiago, Chile; Division of Pediatrics, School of Medicine, Catholic University of Chile, Santiago, Chile: London School of Hygiene and Tropical Medicine, London, United Kingdom
SCARBOROUGH, ON, June 27, 2018 /CNW/ - TAIBU Community Health Centre is excited to announce that it will be celebrating its 10thAnniversary – Decade of Excellence – at a Gala Dinner to be held on June 30th 2018 at the Brighton Convention Centre in Scarborough.

Since its establishment, TAIBU CHC has been providing quality and culturally appropriate primary health care and related services for the Black communities across the Greater Toronto Area as its priority population and all the residents of our local community of the Malvern Neighborhood. TAIBU has demonstrated its capacity to engage the community that it serves in a meaningful way recognizing that various social determinants of health play a significant role in affecting the way racialized communities access health and social services. Over the years of its existence, TAIBU has received several awards, commendations and acknowledgment for its journey towards excellence.
In 2017, the Board of Directors of TAIBU CHC launched its 5 years strategic direction titled RISE – Excellence in Black Community Health. This is in furthering the vision of the founding fathers for TAIBU to become a centre of excellence for developing best practices for working with the Black and other racialized communities.
"The Board of Directors and I are looking forward, with great excitement, to celebrating our 10th Anniversary – Decade of Excellence. We are so very thankful for the hard work and great vision of the founding members of TAIBU and our past members of our Board of Directors. Building on their joint successes, the Board and I continue to work diligently in governing the organization. We are focused on providing committed leadership to ensure that TAIBU meets its mandate of serving its priority population across the GTA and become a recognized stakeholder in the delivery of excellent primary care and community capacity programs and services for racialized communities. In addition, we have helped to ensure our future successes and continuous improvement through the development of our strategic priorities that we will be working to implement over the next five years. We look forward to another decade of excellence". Debra Wight, President of the Board of Directors, TAIBU CHC
2018 marks TAIBU's 10 years of services and we extend our invitation to all our partners, stakeholders and the community at large to join us during this celebration event to acknowledge the relationship that we have enjoyed over the past decade and celebrate our collective achievements. This event will highlight our successes and measured outcomes in improving, promoting and maintaining the health and well-being for Indigenous, Black, Francophone and other racialized communities we served through quality and culturally designed primary healthcare services and strategies.
"We are very excited and looking forward to celebrating this significant milestone with the staff, volunteers, clients and our partners. Over the past decade we have worked very hard to engage the community in planning, developing and delivering innovative programs and services. The event is also to reinforce our commitment to our clients and the community for continuing our journey towards excellence in community services. The celebration will feature local entertainers, a notable keynote speaker, recognition awards, testimonies and acknowledgments. We hope to see you all!" Liben Gebremikael – Executive Director, TAIBU CHC.
TAIBU Community Health Centre's mission is to provide primary health care and related services for Black populations across the Greater Toronto Area as its priority population and residents of the local community of Malvern. Recognizing that systemic oppression has fostered conditions of ill-health with Black communities, we strive to deliver these services through intersectional, equity-based and culturally affirming practices which promote holistic wellness, health education, and prevention.
SOURCE TAIBU Community Health Centre